Delivery Order SPE2DB22D2206-SPE2DB25FJN84
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Tafinlar 50 mg capsules (120-count units) under a firm fixed-price contract valued at $27,672.52. This delivery order is expected to be completed by August 20, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania location. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen Drug Corp's demonstrated...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Tafinlar 75 mg capsules (120-count units) under a firm fixed-price contract valued at $8,896.41. The award was issued on August 5, 2025, with an ultimate completion date of August 26, 2025. This non-set-aside competitive award represents a continuation of AmerisourceBergen's critical role as a pharmaceutical distributor supporting federal medical procurement needs, particularly for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Tafinlar 75 mg capsules (120 count) with a ceiling value of $8,896.41. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to support federal medical procurement needs. The order is scheduled for completion by September 12, 2025, and will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,792.82 firm fixed-price contract is for the supply of 4,568,120,296 units of the prescription medication Tafinlar 75 mg capsule. The contract has a period of performance through May 23, 2025. This award is not associated with a set-aside program and is part of a larger $999,999,999.00 Indefinite Delivery Contract...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the cancer medication Tafinlar (50 mg capsules). The contract has a firm fixed price of $30,424.90 and a performance period ending on May 22, 2025. It is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 120 capsules of the pharmaceutical drug TAFINLAR 75 mg. The $8,139.33 contract has a completion date of February 7, 2024 and was awarded on January 17, 2024. Amerisourcebergen Drug Corp has a history of providing pharmaceutical products and related distribution services to DLA Troop Support Medical under similar contracts...
- This is a federal contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TAFINLAR 50 MG CAPSULE 120S, a pharmaceutical product. The contract is a delivery order with a firm fixed price of $13,836.26 and a completion date of June 30, 2025. The contract is not set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,792.84 firm fixed-price delivery order is for the pharmaceutical product TAFINLAR 75MG CAP 120S. This is not a set-aside contract. The award is associated with AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TAFINLAR 75MG CAP 120S, a pharmaceutical product. The contract has a firm fixed price, with a ceiling value of $8,896.42, and a period of performance through July 3, 2025. The contract is not set aside and is an open competition. Amerisourcebergen...
- The Defense Logistics Agency awarded a delivery order valued at $22,892.70 to AmerisourceBergen Drug Corp for the supply of Tadliq 20 mg/5 ml suspension (150 ml) on August 4, 2025, with an ultimate completion date of August 5, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The place of performance is Conshohocken, Pennsylvania, where AmerisourceBergen's Corporate Office is headquartered. This delivery order is a child contract issued under...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJN84Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Tafinlar 50 mg capsules (120 count) at a firm fixed price of $13,836.26. This is a non-set-aside contract with an ultimate completion date of September 12, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a purchase under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, maintains an extensive portfolio of federal medical supply contracts with the Defense Logistics Agency. The company's contracts demonstrate consistent capability to fulfill competitive federal procurement requirements across a broad spectrum of pharmaceutical products, including specialty medications, brand-name and generic drugs, and medical supplies supporting military and veteran healthcare systems. This award reflects AmerisourceBergen's role as a critical vendor within the DLA's Medical Supply Chain and aligns with the agency's plans to establish multiple regional pharmaceutical prime vendor contracts to support global defense health operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.8k | 8/21/25 |